Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
US8815901B2 · kind B2 · utility
39Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2013 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Aug 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I)wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, N-oxide thereof; processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.